InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,188.00
(
-0.40%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
-0.66%
)
Bitcoin
60,193.61
(
-2.30%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 182

Friday, 06/01/2018 10:47:15 AM

Friday, June 01, 2018 10:47:15 AM

Post# of 438
ONCS hired former AVXS CEO Daniel OConnor. How responsible was he for AVXS technological innovation? I don't know.

ONCS technology involves localized injection of a cytokine into tumor followed by the delivery of electrical pules

Preliminary data in the combo therapy with Keytruda will be presented in 2018.

Breakthrough Therapy & Fast Track Designations are possibilities.

2/28/18, Cash = $37.6mn giving them a runway into Q4/2018.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up